Voyong Fund
沃永基金
Voyong Fund (沃永基金) is a venture capital fund that co-led the over-100-million-RMB Pre-A round of PAM2L Biotechnologies (柏垠生物) in January 2023, alongside Yunqi Capital and Fuhua Capital. The deal, which also saw follow-on investment from Cornerstone Capital and Yayi Capital, was for a synthetic biology company founded in March 2021 by researchers from the Chinese Academy of Sciences. elsewhere's corpus does not contain additional information about Voyong Fund's founding, team, or broader investment strategy beyond this single transaction.
AI-generated — may contain errors, please verify.
Coverage
二月，回归对世界的想象力 | 5Y News Monthly
上个月发生的大事儿。
五源资本·5Y News | Portfolio Company PAM2L Biotechnologies Closes Pre-A Round of Over 100 Million RMB
Leveraging synthetic biology and machine learning as dual engines to drive bio-based materials and product development.
五源资本·"Bioyen Bio" Closes Over 100 Million Yuan Pre-A Round, Led by Yunqi Capital | Yunqi Capital
Leading research in materials synthetic biology, building an efficient innovation R&D platform
云启资本·
